Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM

• Status: COMPLETED
• Trial end date: 2025-04-22

Summary

This is an exploratory study evaluating CS0159 in combination with Semaglutide in MASH patients with obesity and T2DM.

• Phase: NA

Details

• Lead Sponsor: Shanghai Jiao Tong University School of Medicine